Stellar Biotechnologies is the leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH). We serve the growing demand for this essential molecule and we are focused on applying our expertise to the rapidly-evolving field of immunotherapy development.
Channels of Communication
Stellar announces material information, including material financial information, to its investors using this Site, press releases, SEC filings, and public conference calls and webcasts. These are Stellar’s primary channels of communication with its shareholders. The Company intends to use social media channels, accessible via link from this Site, as additional means for disclosure of information about the Company, its technology, industry and activities and to communicate educational content about its products and services and other matters and to comply with its disclosure obligations under Regulation FD.